ARTICLE | Company News
DrugAbuse other research news
December 4, 2000 8:00 AM UTC
DrugAbuse received a $100,000 Phase I SBIR grant from the National Institute on Drug Abuse to develop its Buprel once monthly formulation of buprenorphine, which uses the company's Lactiz sustained re...